Stock Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Change in Restricted Stock Unit

The following table summarizes information about the changes in restricted stock units for the years ended December 31, 2023, 2022 and 2021, respectively.

	For the year ended					For the year ended					For the year ended
	December 31, 2023					December 31, 2022					December 31, 2021
	Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value		Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value		Restricted Stock Units Outstanding		Weighted Average Grant Date Fair Value
Balance at beginning of period		39,657		$	47.83		22,597		$	48.91		—	$	—
Grants		33,294			29.53		24,833			47.19		22,597		48.91
Vesting		(14,553	)		48.00		(7,425	)		48.91		—		—
Forfeited/expired		(4,581	)		41.09		(348	)		48.91		—		—
Balance at end of period		53,817		$	37.04		39,657		$	47.83		22,597	$	48.91

Schedule of Change in Performance Stock Units

The following table summarizes information about the changes in PSUs as of and for the years ended December 31, 2023, 2022 and 2021, respectively.

	For the year ended					For the year ended					For the year ended
	December 31, 2023					December 31, 2022					December 31, 2021
	Performance-Based Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value		Performance-Based Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value		Performance-Based Restricted Stock Units Outstanding		Weighted Average Grant Date Fair Value
Balance at beginning of period		47,082		$	48.00		22,597		$	48.91		—	$	—
Grants		33,294			29.53		24,833			47.19		22,597		48.91
Vesting		—			—		—			—		—		—
Forfeited/expired		(5,149	)		41.95		(348	)		48.91		—		—
Balance at end of period		75,227		$	40.24		47,082		$	48.00		22,597	$	48.91

Schedule of Analysis of Stock Option Activity

An analysis of stock option activity for the year ended December 31, 2023 is presented in the table and narrative below:

	Shares			Weighted- Average Ex. Price		Weighted- Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value ($000)
Outstanding, beginning of year		1,490,413		$	29.99
Granted		253,228			29.53
Exercised		(125,593	)		17.76
Cancelled		(65,799	)		40.79
Outstanding, end of year		1,552,249			30.45		5.81	$	6,814
Exercisable at end of year		895,121		$	25.34		4.04	$	6,550

Schedule of Information Concerning Outstanding and Vested Stock Options

The following table summarizes information concerning outstanding and vested stock options as of December 31, 2023:

Exercise Price		Number Outstanding		Remaining Contracted Life (Years)		Number Vested
$	16.95		214,981		1.8		214,981
$	21.18		392,477		3.4		392,477
$	29.70		293,760		5.5		167,340
$	34.55		10,200		6.1		3,900
$	48.91		180,764		7.6		72,841
$	47.19		215,043		8.6		43,582
$	29.53		245,024		9.6		—

Summary of Vested and Unvested Restricted Stock Outstanding

The following table summarizes information about vested and unvested restricted stock.

	For the year ended					For the year ended					For the year ended
	December 31, 2023					December 31, 2022					December 31, 2021
	Restricted Stock Outstanding			Weighted Average Grant Date Fair Value		Restricted Stock Outstanding			Weighted Average Grant Date Fair Value		Restricted Stock Outstanding			Weighted Average Grant Date Fair Value
Balance at beginning of period		24,813		$	36.21		46,598		$	35.75		95,888		$	29.89
Grants		25,190			27.79		15,425			40.89		12,110			49.58
Vesting		(23,708	)		36.40		(37,010	)		37.61		(60,011	)		29.25
Forfeited/expired		(1,105	)		29.70		(200	)		29.70		(1,389	)		32.76
Balance at end of period		25,190		$	27.79		24,813		$	36.21		46,598		$	35.75